903. Deputy Conor Sheehan asked the Minister for Health the number of validated applications submitted by clinicians for Glucagon-like peptide-1, GLP-1, therapies under the drugs payment scheme that were rejected by the primary care reimbursement service, PCRS, system on account of diabetes only automated controls; and if she will make a statement on the matter. [49596/26]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
925. Deputy Pat Buckley asked the Minister for Health if a treatment (details supplied) can be made available under the medical card and the drugs payment scheme. [49703/26]
414. Deputy Paul McAuliffe asked the Minister for Health if she will consider approving the payment of off-label low dose naltrexone as part of the drugs payment scheme for the treatment of long-Covid patients; and if she will make a statement on the matter. [48375/26]
421. Deputy Albert Dolan asked the Minister for Health if she will provide an update on the consideration by the HSE senior leadership team of the reimbursement application for givinostat; whether a decision has now been reached following the recommendation submitted by the Drugs Group on 9 June 2026; and if she will make a statement on the matter. [48421/26]
466. Deputy Albert Dolan asked the Minister for Health the reason skyclarys has not been included on the agenda for the recent HSE Drugs Group meeting held in June 2026; when the drug will be considered by the Drugs Group; the timeline for a decision on its prioritisation within the reimbursement process; and the measures being taken to ensure there are no further avoidable delays in progressing access to skyclarys f…
504. Deputy David Cullinane asked the Minister for Health the estimated cost of reducing the drug payment scheme threshold to €60, €40, €20, €15, €10, €5 and €0, in tabular form. [48653/26]
514. Deputy David Cullinane asked the Minister for Health the estimated cost of a 10% uplift in spending on new medicines. [48663/26]
540. Deputy Paul Lawless asked the Minister for Health the reason a necessary prescribed medication (MoviPrep), which is required to prepare a patient for a colonoscopy procedure, is not covered under the medical card scheme; if her attention has been drawn to the financial burden this places on patients in receipt of disability allowance or other social welfare supports; and her plans to review or extend medical car…
273. Deputy Naoise Ó Cearúil asked the Minister for Health whether consideration will be given, as part of the ongoing review of medicines reimbursement, to strengthen and formalise the role of the Rare Disease Technology Review Committee; whether she will consider ensuring its early, consistent and structured involvement alongside the health technology assessment process in order to improve timely access to orphan m…
711. Deputy David Cullinane asked the Minister for Health the target and actual generic substitution rate for each health region; and her plans for improving generic substitution and improvements in medicines spending efficiency. [47075/26]
727. Deputy Shane Moynihan asked the Minister for Health when a drug treatment for neurofibromatosis (details supplied) will be made available for patients by the HSE. [47109/26]
728. Deputy Shane Moynihan asked the Minister for Health when a drug treatment for neurofibromatosis (details supplied) will be made available for patients by the HSE. [47110/26]
729. Deputy Conor Sheehan asked the Minister for Health if she plans to broaden the reimbursement criteria for GLP-1 medications, such as ozempic, under the drugs payment scheme or long-term illness scheme to include patients diagnosed with metabolic disorders, including polycystic metabolic syndrome and polycystic ovary syndrome, where insulin resistance is a core clinical symptom; her views on whether she intends t…
739. Deputy Erin McGreehan asked the Minister for Health the status of negotiations regarding belzutifan, noting that the HSE is currently engaged in pricing discussions with a company (details supplied).; and if she will make a statement on the matter. [47251/26]
740. Deputy Natasha Newsome Drennan asked the Minister for Health if a proposal for the reimbursement of vamorolone (Agamree) under the HSE drug reimbursement scheme has been submitted to the HSE Drugs Group; and if she will make a statement on the matter. [47252/26]
741. Deputy Séamus McGrath asked the Minister for Health for an update on the approval of a drug for Von Hippel Lindau syndrome [47257/26]
802. Deputy Niamh Smyth asked the Minister for Health if she will provide an update on the reimbursement process for skyclarys for the treatment of Friedreich's Ataxia; the meetings that have taken place to date regarding the application; when a final decision is expected; and if she will make a statement on the matter. [47506/26]
805. Deputy John Brady asked the Minister for Health if she will intervene to ensure that the HSE prioritises a conclusion to the skyclarys reimbursement negotiations; if she will commit to the inclusion of the drug on the agenda of the next HSE drugs group meeting; and if she will make a statement on the matter. [47509/26]
898. Deputy Colm Burke asked the Minister for Health the steps being taken to ensure that a life-changing prostate cancer medication, RLT, known as Pluvicto, will be made available to medically suitable patients; and if she will make a statement on the matter. [47846/26]
899. Deputy Joe Neville asked the Minister for Health to update Dáil Éireann on the 10 June 2026 statement of the Beneluxa countries on a unified approach to access to and affordability of medicines; her Department’s engagement in 2026 with Beneluxa countries on this initiative; the possible advancements in pharmaceutical procurement across the Beneluxa countries in 2026 and 2027; and if she will make a statement on …
457. Deputy Aengus Ó Snodaigh asked the Minister for Health when selpercatinib (details supplied) will be made available here. [46451/26]
471. Deputy Paul Lawless asked the Minister for Health the reason a commonly prescribed diuretic water tablet has been removed from the list of medications covered under the medical card and/or drugs payment scheme (details supplied); the number of patients affected by this change; whether an impact assessment was carried out in advance of this decision, particularly in relation to patients with chronic conditions an…
472. Deputy Pádraig Mac Lochlainn asked the Minister for Health the current status of the reimbursement process for givinostat for children living with Duchenne muscular dystrophy; the steps being taken to ensure urgent access, clear timelines and no further delays; and if she will make a statement on the matter. [46503/26]
485. Deputy Pádraig O'Sullivan asked the Minister for Health whether the medicine belzutifan (welireg) is available for the treatment of patients with Von Hippel-Lindau disease in Ireland; whether it is eligible for reimbursement by the HSE; and if she will make a statement on the matter. [46535/26]
486. Deputy Pádraig O'Sullivan asked the Minister for Health whether the medicine daraxonrasib is available for the treatment of patients with pancreatic cancer in Ireland; whether it is or will be eligible for reimbursement by the HSE; and if she will make a statement on the matter. [46536/26]